Unbiased AI-powered news
2 stories related to this topic, newest first.
EuronewsRoche announced Tuesday that its Elecsys pTau217 test, the first blood test designed to signal and rule out Alzheimer’s disease, has been cleared for use across the European Union. Developed with Eli Lilly and Company, the test aims to speed diagnosis for millions facing lengthy…
Substrate placeholder — needs reviewEli Lilly and Company has introduced Foundayo, the brand name for orforglipron, an oral GLP-1 receptor agonist approved for weight management. The pill offers a non-injectable alternative to existing treatments in the growing obesity drug market. Availability begins in the US, ta…